
Implications for Clinical Practice from a Multicenter Survey of Heart Failure Management Centers
2021; Elsevier BV; Volume: 76; Linguagem: Inglês
10.6061/clinics/2021/e1991
ISSN1980-5322
AutoresEdimar Alcides Bocchi, Henrique Turin Moreira, Juliana Sanajotti Nakamuta, Marcus Vinı́cius Simões, Alberto de Almeida Las Casas, Altamiro Reis da Costa, Amberson Vieira de Assis, André Rodrigues Durães, Antônio Carlos Pereira-Barretto, Antonio Delduque de Araujo Ravessa, Ariane Vieira Scarlatelli Macedo, Bruno Biselli, Carolina Maria Nogueira Pinto, Conrado Roberto Hoffmann Filho, Costantino Costantini, Dirceu Rodrigues Almeida, Edval Gomes dos Santos, Erwin Soliva, Estêvão Lanna Figueiredo, Felipe N. Albuquerque, Felipe da Silva Paulitsch, Fernando Carvalho Neuenschwander, José A. Figueiredo, Flávio de Souza Brito, Heno Ferreira Lopes, Humberto Villacorta, João David de Souza, João Mariano Sepulveda, José Carlos Aidar Ayoub, José Fernando Vilela-Martin, Juliano Novaes Cardoso, Laercio Uemura, Lídia Zytynski Moura, Lília Nigro Maia, Lúcia Brandão de Oliveira, Lucimir Maia, Luís Beck da Silva Neto, Luís Henrique Wolff Gowdak, Luiz Cláudio Danzmann, Marcus Vinícius Melo de Andrade, Maria Christiane Valéria Braga Braile-Sternieri, Maria da Consolação Vieira Moreira, Olimpio R França, Otávio R. Coelho‐Filho, Paulo Frederico Esteves, Priscila Raupp-da-Rosa, Ricardo Jorge de Queiroz e Silva, Ricardo Mourilhe‐Rocha, Ruy F. Viegas, Salvador Rassi, Sandrigo Mangili, Sérgio Kaiser, Sílvia Marinho Martins Alves, Vitor Sérgio Kawabata,
Tópico(s)Health, Nursing, Elderly Care
ResumoThis observational, cross-sectional study based aimed to test whether heart failure (HF)-disease management program (DMP) components are influencing care and clinical decision-making in Brazil.The survey respondents were cardiologists recommended by experts in the field and invited to participate in the survey via printed form or email. The survey consisted of 29 questions addressing site demographics, public versus private infrastructure, HF baseline data of patients, clinical management of HF, performance indicators, and perceptions about HF treatment.Data were obtained from 98 centers (58% public and 42% private practice) distributed across Brazil. Public HF-DMPs compared to private HF-DMP were associated with a higher percentage of HF-DMP-dedicated services (79% vs 24%; OR: 12, 95% CI: 94-34), multidisciplinary HF (MHF)-DMP [84% vs 65%; OR: 3; 95% CI: 1-8), HF educational programs (49% vs 18%; OR: 4; 95% CI: 1-2), written instructions before hospital discharge (83% vs 76%; OR: 1; 95% CI: 0-5), rehabilitation (69% vs 39%; OR: 3; 95% CI: 1-9), monitoring (44% vs 29%; OR: 2; 95% CI: 1-5), guideline-directed medical therapy-HF use (94% vs 85%; OR: 3; 95% CI: 0-15), and less B-type natriuretic peptide (BNP) dosage (73% vs 88%; OR: 3; 95% CI: 1-9), and key performance indicators (37% vs 60%; OR: 3; 95% CI: 1-7). In comparison to non- MHF-DMP, MHF-DMP was associated with more educational initiatives (42% vs 6%; OR: 12; 95% CI: 1-97), written instructions (83% vs 68%; OR: 2: 95% CI: 1-7), rehabilitation (69% vs 17%; OR: 11; 95% CI: 3-44), monitoring (47% vs 6%; OR: 14; 95% CI: 2-115), GDMT-HF (92% vs 83%; OR: 3; 95% CI: 0-15). In addition, there were less use of BNP as a biomarker (70% vs 84%; OR: 2; 95% CI: 1-8) and key performance indicators (35% vs 51%; OR: 2; 95% CI: 91,6) in the non-MHF group. Physicians considered changing or introducing new medications mostly when patients were hospitalized or when observing worsening disease and/or symptoms. Adherence to drug treatment and non-drug treatment factors were the greatest medical problems associated with HF treatment.HF-DMPs are highly heterogeneous. New strategies for HF care should consider the present study highlights and clinical decision-making processes to improve HF patient care.
Referência(s)